Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
LXEO Lexeo Therapeutics
- 4.640
- -0.070-1.49%
Close May 2 16:00 ET
- 4.850
- +0.210+4.53%
Post 19:52 ET
154.03MMarket Cap-1.50P/E (TTM)
5.550High4.585Low1.27MVolume4.810Open4.710Pre Close6.39MTurnover5.84%Turnover RatioLossP/E (Static)33.20MShares19.50052wk High1.32P/B100.61MFloat Cap1.45052wk Low--Dividend TTM21.68MShs Float22.330Historical High--Div YieldTTM20.49%Amplitude1.450Historical Low5.048Avg Price1Lot Size
Lexeo Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -36.40%-81.15M | -102.60%-28.33M | -27.65%-17.81M | -52.76%-20.15M | 19.09%-14.87M | -9.05%-59.5M | 15.91%-13.98M | -18.32%-13.95M | -13.19M | -18.37M |
| Net income from continuing operations | -48.11%-98.33M | -82.73%-25.92M | -46.65%-29.49M | -58.00%-21.24M | -16.21%-21.68M | -12.01%-66.39M | 2.68%-14.19M | -17.90%-20.11M | ---13.44M | ---18.66M |
| Depreciation and amortization | 8.63%2M | 6.33%521K | 10.65%509K | 11.21%496K | 6.49%476K | 60.96%1.84M | 10.11%490K | 34.50%460K | --446K | --447K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | --530K | --258K | ---- | ---- | ---- |
| Change In working capital | 84.14%2.73M | -376.00%-6.41M | 62.14%7.38M | -93.65%-2.26M | 814.44%4.01M | -17.25%1.48M | 55.36%-1.35M | 1.36%4.55M | ---1.17M | ---561K |
| -Change in prepaid assets | -270.71%-1.69M | -397.99%-2.08M | -513.64%-270K | 557.98%861K | -138.36%-201K | 152.46%990K | 184.30%698K | -109.89%-44K | ---188K | --524K |
| -Change in payables and accrued expense | 200.63%5.75M | -129.66%-3.96M | 57.08%7.99M | -297.59%-2.81M | 707.25%4.52M | -52.56%1.91M | 13.18%-1.73M | 20.31%5.09M | ---706K | ---745K |
| -Change in other current liabilities | 6.55%-1.33M | -14.15%-363K | 31.02%-338K | -14.39%-310K | 7.35%-315K | -366.78%-1.42M | -59.80%-318K | -170.72%-490K | ---271K | ---340K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -36.40%-81.15M | -102.60%-28.33M | -27.65%-17.81M | -52.76%-20.15M | 19.09%-14.87M | -9.05%-59.5M | 15.91%-13.98M | -18.32%-13.95M | ---13.19M | ---18.37M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -56,916.36%-94.08M | -128,095.89%-93.58M | -56.60%-83K | -458.97%-218K | -193K | 81.69%-165K | 31.78%-73K | 86.75%-53K | -39K | 0 |
| Net PPE purchase and sale | -318.26%-481K | --0 | -2,666.67%-83K | -446.15%-213K | ---185K | 82.89%-115K | -192.00%-73K | 99.16%-3K | ---39K | --0 |
| Net intangibles purchase and sale | --0 | --13K | --0 | ---5K | ---8K | 78.17%-50K | --0 | -13.64%-50K | --0 | --0 |
| Net investment purchase and sale | ---93.6M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -56,916.36%-94.08M | -128,095.89%-93.58M | -56.60%-83K | -458.97%-218K | ---193K | 81.69%-165K | 31.78%-73K | 86.75%-53K | ---39K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -14.47%88.78M | -100.10%-97K | -101.84%-72K | 409.57%291K | 90,563.27%88.65M | 54,815.87%103.79M | 123,644.44%100.07M | 11,277.14%3.91M | -94K | -98K |
| Net issuance payments of debt | -111.47%-410K | -10.48%-116K | -102.85%-111K | 28.16%-74K | 0.91%-109K | 2,293.25%3.58M | 2.78%-105K | 10,913.89%3.89M | ---103K | ---110K |
| Net common stock issuance | -11.53%88.7M | -100.00%-4K | --0 | ---54K | --88.75M | --100.25M | --100.25M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 862.75%491K | --23K | 30.00%39K | 4,555.56%419K | -16.67%10K | -84.64%51K | --0 | --30K | --9K | --12K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---86K | ---75K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -14.47%88.78M | -100.10%-97K | -101.84%-72K | 409.57%291K | 90,563.27%88.65M | 54,815.87%103.79M | 123,644.44%100.07M | 11,277.14%3.91M | ---94K | ---98K |
| Net cash flow | ||||||||||
| Beginning cash position | 54.76%124.72M | 314.13%160.27M | ---- | ---- | 54.76%124.72M | -40.68%80.59M | -60.27%38.7M | ---- | ---- | --80.59M |
| Current changes in cash | -295.90%-86.45M | -241.84%-122.01M | ---- | ---- | 498.41%73.59M | 179.84%44.13M | 611.58%86.02M | ---- | ---- | ---18.47M |
| End cash Position | -69.32%38.27M | -69.32%38.27M | ---- | ---- | 219.26%198.31M | 54.76%124.72M | 54.76%124.72M | ---- | ---- | --62.12M |
| Free cash flow | -36.83%-81.63M | -101.46%-28.31M | -27.76%-17.89M | -53.96%-20.37M | 18.04%-15.06M | -7.57%-59.66M | 16.01%-14.05M | -14.87%-14M | ---13.23M | ---18.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
BRK cash at new high: What to expect from Buffett’s meeting?
🎙️Discussion 1. Buffett said he won't sell Japanese stocks for the next ten years. What's your take? 2. In the face of market changes, do y
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now